Department of Gynecology, Jingmen First people's Hospital, Jingmen, Hubei 448000, China.
Department of Ultrasound, Jingmen First people's Hospital, Jingmen, Hubei 448000, China.
Scanning. 2022 Jun 6;2022:5444552. doi: 10.1155/2022/5444552. eCollection 2022.
For the postoperative treatment of oocyte carcinoma, CT and CT ultrasonography combined with microscopic intraperitoneal should be combined with peritoneal heat perfusion chemotherapy. The authors selected 50 patients who received treatment for ovarian cancer from 2017 to 2018 and divided them into two groups (observation group, 30 cases, control group, 20 cases). Cisplatin, associated with peritoneal hyperthermia, led the control group, and we monitored all patients for 1 year and provided clinical trials, lifestyle, and results for both disease group. The experimental results showed that the target reduction rate of the control group was 70%, while that of the control group was only 40%, lower than that of the control group < 0.05. The life expectancy of the control group was higher than that of the control group, < 0.05. Nausea, vomiting, diarrhea, bone marrow compression, and constipation in the study group were slightly higher than those in the control group (35%), but there was no significant difference between the two groups ( > 0.05). Chemotherapy combined with intraperitoneal infusion of loplatin has no side effects, helps improve survival, and can be used in a variety of clinical trials.
对于卵黄囊瘤的术后治疗,应采用 CT 和 CT 超声联合显微镜下腹腔检查与腹腔热灌注化疗相结合的方法。作者选择了 2017 年至 2018 年间接受卵巢癌治疗的 50 名患者,并将其分为两组(观察组 30 例,对照组 20 例)。对照组采用顺铂联合腹腔热疗,监测所有患者 1 年,并提供临床试验、生活方式和疾病组的结果。实验结果表明,对照组的肿瘤缩小率为 70%,而观察组仅为 40%,低于对照组 < 0.05。观察组的预期寿命高于对照组,< 0.05。观察组恶心、呕吐、腹泻、骨髓抑制和便秘的发生率略高于对照组(35%),但两组间无显著性差异(> 0.05)。顺铂联合腹腔内灌注化疗无明显副作用,有助于提高生存率,可用于多种临床研究。